# The Pharmacokinetics of MK-7145 Following Single Dose Administration in Participants With Moderate Renal Insufficiency (MK-7145-018)

> **NCT01832103** · PHASE1 · WITHDRAWN · sponsor: **Merck Sharp & Dohme LLC**

## Conditions studied

- Renal Insufficiency

## Interventions

- **DRUG:** MK-7145

## Key facts

- **NCT ID:** NCT01832103
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-08
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01832103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01832103, "The Pharmacokinetics of MK-7145 Following Single Dose Administration in Participants With Moderate Renal Insufficiency (MK-7145-018)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01832103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*